Cargando…
Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma
Metastatic melanoma remains the deadliest form of skin cancer. Immune checkpoint inhibition (ICI) immunotherapy has defined a new age in melanoma treatment, but responses remain inconsistent and some patients develop treatment resistance. The myriad of newly developed small molecular (SM) inhibitors...
Autores principales: | Chacon, Alexander C., Melucci, Alexa D., Qin, Shuyang S., Prieto, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005112/ https://www.ncbi.nlm.nih.gov/pubmed/33810078 http://dx.doi.org/10.3390/ijms22063228 |
Ejemplares similares
-
Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
por: Qin, Shuyang S., et al.
Publicado: (2021) -
Thinking big with small molecules
por: Mruk, Karen, et al.
Publicado: (2015) -
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
por: Bulfone, Tommaso C., et al.
Publicado: (2018) -
IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
por: Liu, Hongmei, et al.
Publicado: (2022) -
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition
por: Adderley, Helen, et al.
Publicado: (2019)